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Abstract.  The integrin  ~6/34 is a heterodimer predomi- 
nantly expressed by epithelia.  While no definite recep- 
tor function has yet been assigned to it, this integrin 
may mediate adhesive and/or migratory  functions of 
epithelial cells. We have determined the complete pri- 
mary structure of both the as and/34  subunits from 
cDNA clones isolated from pancreatic carcinoma cell 
line libraries.  The deduced amino acid sequence of or6 
is homologous to other integrin  o~ chains (18-26% 
identity).  Antibodies to an a6 carboxy terminus pep- 
tide immunoprecipitated  0t6~4 complexes from carci- 
noma cells and 0t6/31 complexes from platelets, provid- 
ing further evidence for the association of ~6 with 
more than one t3 subunit.  The deduced amino acid se- 
quence of/34 predicts an extracellular portion homolo- 
gous to other integrin/3  chains,  and a unique cyto- 
plasmic domain comprised of >  1,000 residues.  This 
agrees with the structures of the ~4 cDNAs from nor- 
mal epithelial cells (Suzuki,  S.,  and Y.  Naitoh.  1990. 
EMBO [Eur. Mol.  Biol.  Organ.] J.  9:757-763;  Hoger- 
vost, E,  I.  Kuikman,  A.  E.  G. Kr.  von dem Borne, 
and A.  Sonnenberg.  1990.  EMBO [Eur. Mol. Biol. 
Organ.] J.  9:765-770).  Compared to these structures, 
however, the /~4 cDNAs that we have cloned from car- 
cinoma cells contain extra sequences. One of these is 
located in the 5'-untranslated  region, and may encode 
regulatory sequences. Another specifies a segment of 
70 amino acids in the cytoplasmic tail.  Amplification 
by reverse transcription-polymerase chain reaction of 
mRNA indicated that multiple forms of ~4 may exist, 
possibly due to cell-type specific alternative  splicing. 
The unique structure of/34 suggests its involvement in 
novel cytoskeletal interactions.  Consistent with this 
possibility, 0t6~4 is mostly concentrated on the basal 
surface of epithelial cells, but does not colocalize with 
components of adhesion plaques. 
T 
HE interaction  of cells with the extracellular  matrix is 
important for the formation, maintenance,  and repair 
of tissues as well as for other biological processes such 
as the metastasis of cancer cells.  This interaction  is medi- 
ated, in part, by a family of cell surface receptors called inte- 
grins (Hynes, 1987; Ruoslahti and Pierschbacher,  1987; Buck 
and Horwitz,  1987). These receptors form a link between 
the extracellular  matrix and the cytoskeleton and may trans- 
mit signals  from the extracellular  to the intracellular  envi- 
ronment that affect cell behavior. 
Integrins are heterodimers comprised of a and/3 subunits, 
that are noncovalently  associated transmembrane glycopro- 
teins.  At least 11 0/chains (Ruostahti  and Giancotti,  1989) 
and 6/3 chains (Sheppard et al., 1990) have been recognized 
in man. Each 0/subunit tends to associate with only one type 
of/3 subunit,  but there are several  exceptions  to this  rule 
(Hemler et al., 1989; Cheresh et al., 1989; Holzmann et al., 
1989; Freed et al.,  1989). 
This is publication No. 6533-IMM from the Research Institute of Scripps 
Clinic. 
We and others have previously reported the identification 
of an integrin  expressed primarily on epithelial-type  cells, 
termed 0/E/34 or  0d6/34 (Kajiji  et al.,  1987, 1989;  Hemler et 
al.,  1989). The alpha subunit,  0/6, also appears  to associate 
with the/3,  integrin subunit and, on platelets,  u6/3~ has been 
shown to function as a laminin receptor (Sonnenberg et al., 
1988). 
Here we report  the  complete cDNA  sequence and  the 
deduced amino  acid  sequence of both the  0/6  and  the  /34 
subunits.  Both  0/6 and  /34 are homologous with  the other 
integrin 0/and/3 chains, respectively. However, they contain 
unique structural  features  which may  suggest  novel  func- 
tional properties. 
Materials and Methods 
Cells 
The human pancreatic carcinoma cell line FG was cultured as described 
previously (Kajiji et al., 1989) in RPMI 1640 supplemented with 10% fetal 
calf serum, 2  mM glutamine, and penicillin-streptomycin (50 IU/ml-50 
#g/m/). The human colon carcinoma cell line LoVo (Drewinko et al., 1976) 
©  The Rockefeller University Press, 0021-9525/90/10/1593/12 $2.00 
The Journal of Cell Biology, Volume 111, October  1990  1593-1604  1593 was cultured in DME supplemented as above. Human platelets were the 
generous gift of Dr. Mark Ginsberg (Research Institute of Scripps Clinic, 
La JoUa,  CA). 
Cell Labeling 
FG  cells (107)  were  metabolically labeled with  [35S]methionine  as  de- 
scribed previously (Kajiji et ai., 1989).  Platelets were surface labeled with 
[125I]sodium iodide and lactoperoxidase essentially as described by Roth 
(1975).  Preparation of nonionic detergent cell extracts, immunoprecipita- 
tion, and analysis by SDS-PAGE have been described previously (Kajiji et 
al.,  1989). 
Antibodies 
The mouse monoclonal antibody S3-41 and the rabbit polyclonal antibody 
5710  recognize 0/aft4 (Kajiji et al.,  1987, 1989).  The rat monoclonal anti- 
body GoH3 (Sonnenberg et al.,  1987),  which is specific for ctr,  was the 
generous gift of Dr. Arnoud Sormenberg (University of Amsterdam, The 
Netherlands). The "anti-o/6 cyto" rabbit antiserum was raised to a synthetic 
pepride (IHAQPSDKERLTSDA) corresponding to the carboxy terminus of 
0/6 based on the deduced amino acid sequence reported here. The mono- 
clonal antibody, AA3, was produced using standard hybridoma procedures 
(Kohler and Milstein,  1975)  from mice immunized with placental 0/6/34 
purified on $3-41 affinity columns (Kajiji et al., 1989). AA3 has been shown 
to be specific for the/34 subunit by immunoprecipitarion and Western blot- 
ring.  Full characterization of this antibody will appear elsewhere (Cooper, 
H. M., and V. Quaranta, manuscript in preparation). 
cDNA Library Screening 
Three different cDNA libraries were constructed (Invitrogen, San Diego, 
CA) from mRNA isolated from FG cells: an oligo-dT primed expression 
library in Xgtll and two plasmid (pTZISR Bst XI; Invitrogen) libraries, one 
oligo-dT primed, and the other random primed. 
The following oligonucleotides were synthesized with a Gene Assembler 
(Pharmacia, Uppsala, Sweden) according to the amino-terminal sequence 
of the mature 0/6 protein (Kajiji et ai.,  1989):  (a) 40-mers with 64-fold 
redundancy covering the first 13 amino acids (FNLDTREDNVIRK) 
5'-TTCAAC  T TAGACACGCGAGAGGACAACGTAATCCGAAAGT-3'. 
C  G  T  T  G  G 
(b) 14-mers covering the complete redundancy of the first 5 amino acids 
(1)  5'-TTTAATCTAGATAC-Y 
C  C  T  C 
(2) 5'-TTTAATCTGGATAC-Y 
C  C  C  C 
(3) 5'-TTTAATTTGGACAC-Y. 
C  C  A  T 
Screening of the random-primed eDNA library was performed with the 40- 
mers, labeled with [3,32p]ATP and I"4 polynucleoride kinase (labeling kit 
from Pharmacia), using low stringency conditions (hybridization at 37°C 
overnight and washes with 2x SSC at room temperature and at 46°C, 30- 
min each). 44 positives were then hybridized with the complete set of 14- 
mers followed by washes in 3.0 M tetramethylammonium chloride (TMAC) 
at progressively higher temperatures as described by Wood et ai., (1985). 
Three clones, 0/6.1, ct6.31, and ct6.44,  remained positive up to the melting 
temperature of 14-mers (46°C). 
The insert from the 0/6.1 eDNA clone was isolated and used to screen 
the oligo-dT primed eDNA library. Preparation of  probes, filters, hybridiza- 
tion, and washes were performed according to Maniatis et al.  (1982). 
The ),gtll library ("-,1 ×  106 plaques) was screened (Young and Davis, 
1983) with the rabbit antiserum 5710, which was raised against purified hu- 
man 0/6B4 and previously shown by Western blots to react predominantly 
with/34 (Kajiji et al.,  1989).  72 positive clones from the antibody screen- 
ing were plaque purified and the eDNA inserts were amplified directly from 
bacteriophage  plaques  using  the  polymerase  chain  reaction  (PCR). l 
Briefly, a plug of agar containing the plaque was transferred to 1 ml of SM 
(10 mM Tris-HC1 pH 8.0, 50 mM NaC1, 5 mM MgC12) and incubated for 
either 1 h at room temperature or overnight at 40C.  10/zl of supernatant 
1. Abbreviations used in this paper: ORE open reading frame; PCR, poly- 
merase chain reaction. 
was used in a  50 #1 PCR containing 67 mM Tris-HCl pH 8.8, 1.5 mM 
MgCI2,  10 mM /3-mercaptoethanol, 1.25  U  of TAQ I polymerase, 0.25 
mM each of dATE dTTE dCTE and dGTP, and 0.1 #g each of 24-mer oli- 
gonuclcotides corresponding to sequences of )~gtl  1 flanking the Eco RI 
cloning site. The PCR program consisted of 3 steps: (a) one cycle at 94°C 
for 4 min; (b) 40 cycles of I rain at 94"C, 2 min at 55°C, and 3 rain at 72"C 
with a 5-per cycle extension on the 72°C segment; (c) 10 rain at 72"C and 
a final shift to 4°C. These amplified fragments were isolated using G-ene 
Clean (Bio  101, La Jolla,  CA),  digested with either Eco  RI or Not I, 
repurified with Gene Clean,  and subcloned into pKS+  (Stratagene,  La 
Jolla, CA). 
The 72 positive inserts were arranged into  11 groups based on cross- 
hybridization. Fusion proteins produced by clones representative of a group 
were used to select epitope specific antibodies (Weinberger et al.,  1985) 
from the rabbit antiserum, 5710. These antibodies were tested for their abil- 
ity to immunoprecipitate/34 from a  SDS/heat-denatured FG lysate.  The 
clone lam 18.2.1 (part of a group of 13 crosshybridizers) was identified as 
a/~4 clone by this epitope selection method (Fig. 5 A). The insert from this 
clone was used to screen both of  the plasmid cDNA libraries to isolate over- 
lapping clones. Additional screenings were done using radiolabeled inserts 
from/3,, positive eDNA clones until the complete/34 eDNA was isolated. 
DNA Sequencing 
The 0/6 cDNA clones were sequenced from restriction fragments (Pvu II or 
Sma I for 0/6.1; Ava I + Barn HI or Eco RI +  Hind HI for 0/6.1-7) subcloned 
into pKS+.  The/34 cDNA clones were sequenced from nested deletion 
subclones created using a kit from Pharmacia. Both strands were sequenced 
by dideoxy chain termination (Sanger et al., 1977) either on an ABI 370A 
DNA Sequencer (Applied Biosystems, Inc. Foster City, CA) or manually 
(Sequenase kit; USB, Cleveland, Ohio) using either the T3 and T7 polymer- 
ase vector primer sequences or specific oligonucleotide primers synthesized 
to appropriate regions of the t~ or/~4 sequence. Sequences were analyzed 
on a VAX-VMS version 5.2 computer, with the programs of the University 
of Wisconsin Genetics Computer Group (Devereux et ai.,  1984). 
cDNA Synthesis and PCR 
Poly-A+ RNA was isolated from human placenta and human carcinoma 
cells (Fast Track Kit; Invitrogen). 2-5 #g was used to synthesize cDNAs 
with AMV reverse transcriptase (20 U;  Molecular Genetics Resources, 
Tampa, FL) and 1 #g of  random hexamer primers (Pharmaeia). The cDNAs 
were  extracted with phenol/chloroform, precipitated with ethanol,  and 
resuspended in 100 #1 of water. 1 #1 was amplified using the PCR conditions 
described above except for the primer concentrations (1 #M each) and, for 
reactions using oligos 3  +  4 and oligos 5  +  6, the annealing temperature 
(52°C). The following oligonucleorides were used (see Fig. 6 for number- 
ing; 5' nucleotide is in bold face type):  (a)  (82-98),  (b) (310-329),  (c) 
(4441-4482), (d) (4679--4697),  (e) (4679-4697), and (f) (4805-4820).  10 
#1 of the PCR mixture were separated on a 3.5% acrylamide gel along with 
1 kb molecular size markers (Bethesda Research Laboratories, Gaithers- 
burg, MD) and the DNA was visualized by staining with ethidium bromide. 
To confirm the identity of PCR bands, these were subcloned and se- 
quenced.  Briefly one-haif of PCR  reaction was purified on glass beads 
(Geneclean, Bio  101) and ligated in the Sma I  site of the vector pKS+ 
(Stratagene). Plasmids prepared from bacteria transformed with the ligarion 
mixture were restriction digested and their inserts, if present, were se- 
quenced in both directions as described above. 
Immunofluorescence 
Cultured carcinoma cells were trypsinized, plated on coverslips coated with 
Matrigel (Collaborative Research, Lexington, MA) and cultured for 2 d. 
They were then fixed and stained with appropriate antibodies as described 
(Marehisio et al., 1984).  Briefly, cells were fixed in 3% paraformaldehyde 
for 10 rain at room temperature, permeabilized with the nonionic detergent 
Triton X100 (0.5%) for 5 rain on ice, and then incubated with primary anti- 
bodies:  mouse  monoclonal AA3  specific for human /34, control mono- 
clonal Q5/13  specific for HLA-DR,  a  monoclonal antibody specific for 
vineulin (Sigma Chemical Co., St. Louis, MO), affinity-purified  rabbit anti- 
bodies to talin (a gift from E  Giancotti, La Jolla Cancer Research Foun- 
dation,  La Jolla,  CA),  protein A-purified anti-o/6 cytoplasmic tail anti- 
bodies, control, irrelevant, rabbit immunoglobulin. Aetin was stained with 
fluorescein isothiocyanate-conjugated phalloidin (Sigma Chemical Co.). 
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immunoglobulins,  conjugated  to  either  fluorescein  or  rhodamine  (Sigma 
Chemical  Co.).  Cells  were  viewed  with  a  Zeiss  Axiophot  microscope 
equipped  with  an  epifluorescence  source,  and  photographed  on  Kodak 
T-max  3200. 
Results 
Isolation of  cDNA Clones Encoding tr6 
We have previously isolated the integrin 0/6~4 from human 
carcinoma  cells  and  human  placenta  and  determined the 
amino-terminal  sequence  of both  subunits  (Kajiji  et  al., 
1989). Based on the sequence of the amino terminus for 0/6, 
degenerate oligonucleotides were synthesized and used to 
screen 3  ×  105 colonies from a random primed human pan- 
creatic  carcinoma  (FG)  cDNA  library  as  described  in 
Materials and Methods.  Three clones with inserts of "~1.2 
kb  were  isolated  and  sequenced.  All  three  clones  (0/6.1, 
0/6.31,  and 0/6.44)  overlapped and contained open reading 
frames (ORFs) whose deduced amino acid sequence matched 
exactly the protein sequence of the amino terminus of 0/6 
(Kajiji et al.,  1989;  Hemler et al.,  1989). 
To isolate the rest of the 0/6 gene, "~7.2 ×  105 colonies of 
the oligo-dT primed cDNA plasmid  library was  screened 
with the radiolabeled insert from the 0/6.1 clone. Of 16 posi- 
tive clones, one (0/6.1-7) had an insert of 4.8 kb. Overlapping 
restriction endonuclease fragments of the 0/6 cDNA inserts 
were  subcloned into pKS  and  sequenced in both orienta- 
tions.  Fig.  1 A  shows  the  overall  relationship  of the  0/6 
cDNA clones to one another and the restriction sites relevant 
for subcloning and sequencing. The resulting sequence con- 
sists of 146 bp of the 5'-untranslated region, an ORF of 3,219 
bp encoding 1,078 amino acids, and 2,264 bp of the 3'-un- 
translated region (Fig. 2). 
Analysis of the Primary Structure of  a6 
Preceding the amino terminus of the mature protein is a pos- 
sible signal sequence of 23 amino acids. The mature protein 
is comprised of 1,055 amino acids with a Mr ,~117,000. The 
addition of carbohydrate with an average 2,500 Mr to the 
protein core at the 10 potential N-glycosylation sites (N-X- 
S/T) would result in an estimated size of 142,000 Mr. This 
relative molecular mass corresponds well with the 150,000 
Mr estimated from the migration of 0/6 on SDS-polyacryl- 
amide gels under nonreducing conditions. 
A  hydropathy profile (Kyte and  Doolittle,  1982)  of the 
deduced protein sequence identified a  putative transmem- 
brane region from amino acid residues  1,012-1,037.  After 
this  transmembrane  region  are  36  amino  acids  (residues 
1,038-1,073)  which comprise the presumed cytoplasmic do- 
main. Analysis of the amino-terminal portion of the mole- 
cule revealed seven homologous repeat (domain I, residues 
42-79; II, 113-145; III, 185-217; IV, 256-292; V, 314-352; 
VI, 375-411;  VII, 430-470).  The last three domains each 
contain a sequence motif resembling the cation binding site 
consensus sequence of D-X-D/N-X-D/N-G-X-X-D found in 
a  number of calcium-binding  proteins  (Van  Eldik et al., 
1982). A fourth site, residues 230-238, with weak homology 
to this calcium binding site motif resides between repeated 
domains III and IV. These potential cation binding sites are 
in a region (residues 189-488) of the molecule that is devoid 
of cysteine residues. 
The migration of 0/6 in  SDS-polyacrylamide gels under 
reducing conditions indicated that 0/6 consisted of two poly- 
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Figure 1. Restriction map of the a6 (A) and ~4 
(B) cDNA clones. The ORFs for 0/6 and/3a are 
shown as open bars. The lines indicate the size 
and position of the plasmid and phage cDNA 
clones isolated from the three cDNA libraries. 
Restriction sites relevant to subcloning and se- 
quencing are Ava I (A), Bam HI (B),  Pvu II 
(P), Eco RI (R), and Sma I (S). Representative 
clones out of a total of 54 are shown for/34. 
Tamura  et al.  Primary Structure ofa6~4  1595 1  C~GCC~CGT~C~GGGGGTGGGGC~GGGCGCAGCGGCC~GGAGGCGAAGGTGGCTGCGGTAGCAC~~C~~ 
I01  AGGC~CGCTC-CAGGTCCCCGCTCCCCT  CCOCGTGCGTCCGCCCATGGCCGCCGCCGGGCAGCTGT  GCTTGCTCTACCTGTCGGCGGGGCTCCTGTCC 
M  A  A  A  G  Q  L  C(~L  L  Y  L  S  A  G  L  L  S  18 
201  CGGCTCGGCGCAGCCTTCAACTTGGACACT~C,C~GGACAA~GTGATC~GGAAATATGGAGA~CCGGGAGCCTCTTCGG~GCTGGCCATGCACT 
R  L  G  A  AA F  N  L  D  T  R  ~  D  N  V  I  R  K  Y  G  D  P  G  S  L  F  G  F  S  L  A  M  H  W  52 
301  GGCAACTGCAGCCCGAGGACAAGCC~C~GTGGGGGCCCCGCGCC~AGAAGCGCTT~CACTGCAGAGAGCCTTCAGAAC~A~G 
Q  L  Q  P  E  D  K  R  L  L  L  V  G  A  P  R  G  E  A  L  P  L  Q  R  A  F  R  T  G  G  L  Y  S  85 
401  CTGCGACATCACCGCCCGGGGGCCATGCACGCGGATCGAGTTTGATAACGATGCTGACCCCACGTCAGAAAGCAAGC~GAT~T~CC 
Q  D  I  T  A  R  G  P  (~)  T~  R  I  E  F  D  N  D  A  D  P  T  S  E  S  K  E  D  Q  W  M  G  V  T  118 
501  GTCCAGAGCCAAGGTCCAGGGGGCAAGGTCGTGACATGTGCTCACCGATATGAAAAAAGGCAGCATGTTAATACGAAGCAGGAATCCCGAGACAT  CTTTG 
V  Q  S  Q  G  P  G  G  K  V  V  T  (~  A  H  R  Y  E  K  R  Q  H  V  N  T  K  Q  E  S  R  D  I  F  G  152 
601  GGCGGTGTTATGTCCTGAGTCAGAATCTCAGGATTGAAGACGATATGGATC~GATTGGAG~-F~F1~GTC~TGGGCGATTGAGAGGCCATGAGAAA~ 
R  ~)  Y  V  L  S  Q  N  L  R  I  E  D  D  M  D  G  G  D  W  S  F  ~  D  G  R  L  R  G  H  E  K  F  185 
701  TGGCTCTTGCCAGCA~GTAGCAGCTA~TF~CTAAAGAcTTTCATTACATTGTATTTGGAG~CCCGGGTACTTATAACTGGAAAGGGATTGTTCGT 
Q  Q  G  V  A  A  T  F  T  K  D  F  H  Y  I  V  F  G  A  P  G  T  Y  N  W  K  G  I  V  R  218  G  S 
801  GTAGAGCAAAAGAATAACAc~-r~-FF~TC~CATGAACATCTTTGAAGATGGGCCTTATGAAGTTGGT~GAGACTGAC,CATGATGAAAGTCTCGTTCCTG 
F  D  M  IN  I  F  E  D  G  P  Y  E  l V  G  G  E  T  E  H  D  E  S  L  V  P  V  252  V  E  Q  K  II  N  T  F 
901  TTCCTGCTAACAGTTACTTAC~ITFFI~I'I~f C~CTCAGGGAAAGGTATTGTTT CTAAAGATGAGATCACTTTTGTATCTGGTC~CCCAGAGOCAATCA 
PANSYLGF  SLDSGKGI  VSKDE  I  TFVSGAPRANH  285 
1001  CAGTGGAGCCGTGGTTTTGCTGAAGAGAGACATGAAGTCT  GCACATCTCCTCCCTGAGCACATATTCGATGGAGAAGGTCTGGCCTC~CATTTGGCTAT 
SGAVVLLKRDMK  SAHLLP  EH  I  FDGEGLASSFGY  318 
1101  GATGTGGCGGTGATGGACCTCAACAAGC~TGGGTGGCAAGA~ATAGTTATTGGAGCCCCACAGTA1~F~GA~AGAGATGGA~T~GT~ 
D  VAVMID  L  NK  D  GWQ  DII  V  I  GAP  QY  F  D  RD  G  E  V  GGAV  Y  352 
1201  ATGTCTACAT  GAACCAGCAAGGCAGATGGAATAATGTGAAGCCAATTCGTCTTAATGGAACCAAAGATTCTAT  GTTTGGCATTGCAGTAAAAAATATTGG 
V  Y  M  N  Q  Q  G  R  W  N  N  V  K  P  I  R  L  I~  G  T  K  D  S  M  F  G  I  A  V  K  N  I  G  385 
1301  AGATATTAATCAAGATGGCTAcCCAGATATTGCAGTTGGAGCTCCGTATGATGACTTGGC~G~F~-~ATCTATCATGGATCTGCAAATGGAATAAAT 
ID  I  N  QD  GYP  DII  AV  GAP  Y  D  D  n  GKV  F  I  Y  H  G  SAN  G  I  N  418 
1401  ACCAAACCAACACAGGTTCTCAAGGGTATATCACCTTATTTTGC~TATTCAATTGCT  GGAAACATGGACCTTGATCGAAATT CCTACQCTGATGTTGCTG 
T  K  P  T  Q  V  L  K  G  I  S  P  Y  F  G  Y  S  I  A  G  N  S  ID  L  D  R  N  S  Y  P  D  I V  A  V  452 
1501  TTGG'ITCCCTCTCAGATTCAGTAACTA~rTCAGATC  CCGGCCTGTGATTAATA~TCAGAAAACCATCACAGTAACTCCTAACAC~'f  GACCTCCGCCA 
G  S  L  S  D  S  V  T  I  F  R  S  R  P  V  I  N  I  Q  K  T  I  T  V  T  P  N  R  I  D  L  R  Q  485 
1601  GAAAACAGCGTGTGGGGCGCCTAGTGGC~TATGCCTCCAGGTTAAATCCTGT~TATACTGCTAACCCCGCTGGTTATAATCC~CAATATCAATT 
g  T  A~G  A  P  S  G  I(~L  Q  v  K  S~)F  E  Y  T  A  N  P  A  S  Y  N  P  S  I  S  I  518 
1701  GTC~CACTTC,  AAGCTGAAAAAC,  AA~GAAAATCTGGGCTATCCTCAAGAGTTCAG~CGAAACCAAGGTT  CTGAGCCCAAATATACTCAAGAAC 
V  G  T  L  E  A  E  K  E  R  R  K  S  G  L  S  S  R  V  Q  F  R  N  Q  G  S  E  P  K  Y  T  Q  E  L  552 
1801  TAACTCT  C,AAGAGGCAGAAACAGAAAGTGTGCATGGAC~C~CTGTGGCTAC~TAATATCAGAGATAAACTGCGTCCCATTCCCATAACT  GCCTC 
T  L  K  R  Q  K  Q  K  V  (~  M  E  E  T  L  W  L  Q  D  N  I  R  D  K  L  R  P  I  P  I  T  A  S  585 
1901  AGTGG~GATCCAAGAGCCAAGCTCTCGTAGGCC~GTGAATTCACTTCCAGAAG~CCAATTCTGAA~T~CC~~TA~T 
V  E  I  Q  E  P  S  S  R  R  R  V  N  S  L  P  E  V  L  P  I  L  N  S  D  E  P  K  T  A  H  I  D  618 
2001  GTTCACTTCTTAAAAGAGGGATGTGGAGACGACAATGTATGTAACAGCAACCTTAAACTAGAATATAAATTTTGCACCCGAGAAGGAAATCAAGACAAAT 
2101  TTTCTrATTTACCAATTCAAAAAGGTGTACCAGAAcTAGTTCTAAAAGATCA~TAT.~GCTTTAGAAATAACAGTGACAAACAGCCCTTCCAACCC 
S  Y  L  P  I  Q  K  G  V  P  E  L  V  L  K  D  Q  K  D  I  A  L  E  I  T  V  T  N  S  P  S  N  P  685 
2201  AAGGAATCCCACAAAAGATGG~TGACGCC  CAT  GAGGCTAAACTGATTGCAACGTTTC CAGACACTTTAACCTATTCTGCATATAGAGAACTGA~ 
R  N  P  T  K  D  G  D  D  A  H  E  A  K  L  I  A  T  F  P  D  T  L  T  Y  S  A  Y  R  E  L  R  A  718 
2301  TTCCCT  GAGAAACAG2"f  GAGTTGTGTTGCCAACCAGAATGC~CC~GCT  GACTGTGAGCTC  GCgkAATCL'FI~I"I'AAAAGAAA~TGT~ 
F  P  E  K  e  L  S~VA  N  Q  N  G  S  O  A  D~)E  L  O  N  P  F  K  R  N  S  NV  T  F  Y  752 
2401  ATTTC~dI-FF1"AAGTACAACT GAAGTCACC~CACCOCATATCTGGATATTAATCTGAAGTTAGAAACAACAAGCAATCAAGATAA~'rTGGCTCCAAT 
L  V  L  S  T  T  E  V  T  F  D  T  P  Y  L  D  I  N  L  K  L  E  T  T  S  N  Q  D  N  L  A  P  I  785 
2501  TACAGCTAAAGCA~ATTGAACTGL-FFFI  AT  OGGTCTCGGGAGTTGCTAAACCTTCCCAGGTGTATTTTGGAGGTACAGTTGTTGGOGA~ 
T  A  K  A  K  V  V  I  E  L  L  L  S  V  S  G  V  A  K  P  S  Q  v  y  F  G  G  T  V  V  G  E  Q  818 
2601  GCTATGAAATCTGAAC~TC'AAGTGGGAA~AATAGAGTATGAATTCAGGGTAATAAACTTAGGTAAACCTCTTACAAACCTCGGCACAGCAACCTTGA 
A  M  K  S  E  D  E  V  G  S  L  I  E  Y  E  F  R  V  I  N  L  G  K  P  L  T  N  L  G  T  A  T  L  N  852 
2701  ACATTCAGTGGC~GAAATTAGCAATGGGAAATGGTTGCTTTATTTGGTGAAAGTAGAATcCAAAGGATTGC~GGTAACTTGTGAGCCACAAAA 
I  Q  W  P  K  E  I  S  N  G  K  W  L  L  Y  L  V  K  V  E  S  K  G  L  E  K  V  T  ~  E  P  Q  K  885 
2901  GCTGAAAGAAAATACCAGACTC~AAcTGTAC4DGTGAACGTGAACTGTGTGAACATCAGATGCCCGCTC~GGGGG~CAGCAA~  ~A~ 
3001  TGCC-cTCGAGGTTATGGAACAGCACAT~CTAGAGGAATATTCCAAACTGAACTACTTGGACATTCTCATC42GAGCCTTCATTGATGTGACTGCTGCT  ~ 
R  S  R  L  W  II  S  T  F  L  E  E  Y  S  K  L  N  Y  L  D  I  L  M  R  A  F  1  D  V  T  A  A  A  985 
3101  CGAAAATATCAC~TGCAGGCACTCAGGTT  CGAGTGACTGTGTTTCCCTCAAAGACTGTAGCTCAGTATTCGGGAGTACC~GGTGC~TCAT  C 
E  N  I  R  L  P  N  A  G  T  Q  V  R  V  T  V  F  P  S  K  T  V  A  Q  Y  S  G  V  P  W  W  I  I  1018 
3201  CTAGTGGCTA~TcTC~TCTTGATC~ATTAG5~-TTTATACTATGGAAGTGTGGTTTCTTCAAGAGAAATAAGAAAC~TCATTATGATG 
3301  CCACATATCACAAGGCTGAGATCCATC42TC~TCTC~TAAAGAGAGC42'~ACTTcTGAT~ATAGTATTC~TCTACTTCTGTAA'~.TGTGTGGA~ 
T  Y  H  K  A  E  I  H  A  Q  P  S  D  K  E  R  L  T  S  D  A  1073 
3401  TTAAACGCTCTAGGTACGATGACAGTG~CCCCGATACCATGCTGTAAGGATCCGGAAAGAAGAG~GAGAGATCAAAGATGAAAAGTATATTGATAAC  CT 
3501  TGAAAAAAAACAGTGGATCACAAAGTGGAACAGAAATGAAAGCTACTCATAC~GGGGGCCT  GCTTCACAGTACCCAAACTC~cF~-rITC 
3601  CAACTCAGAAATTCAATTTGGATTTAAAAGCCTGCTCAAT  CCCTGAGGACT  GATqTCAGAGTGACTACACACAGTACGAACCTACAG~~ 
3701  TATTGTTACGTAGCCTAAGGCTCC~F~TIGCACAGCC~TTTAAAACTGTTGGAATGGA  ~'F~-I-IL'TTTAACTGCOGTAATTTAAC~CTGGGTTGCC 
3801  TTTt~-FFFF~.GGCGTC~C~ACATCATGTGTTGGGGAAGGGCCTGCCCAGTTGCACTCAGGTC~CATCCTCCAC~TAGT~A~~C~ 
3901  ACACTCACCTGCACTAACAGAGT GGCCGT  CCTAACCTCGGGCCTC~GCGCAGACGTCCATCACGTTAGCTGTCCCACATCACAAGACTATGC~  ~ 
4001  GTAGTTGTGT~CAACGGAAAGTGCTGTCTTAAACTAAATGTGCAATAGAAGGTGATGTTGC  CATCCTACCGTCTTTTCCTG~CCTAGCT  G'TGTGAAT 
4101  ACCTGCTCACGTCAAAT GCATACAAGT~CATTCTCCC~CACTAAAAACACACAGGTGCAACAC~CTTGAATGCTAGTTATACTTATTTGTATATGGT 
4201  ATTTAT~T~-~CTTTTCTTTACAAA~CATTTTGTTATTGACTAACAGGCCAAAGAGTCTCCAGTTTACCCTTCAGG~GGTTTAATCAATCAGAATTAGA 
4301  ATTAGAGCATGGGAGGGTCATCACTATC~CCTAAATTATTTACTGCA~GAAAATCTTTATAAATGTACCAGAGAGAGTTGTTTTAATAACTTATCTA 
4401  TAAACTATAACCTCTCCTTCATGACAC~CACCCCACAACCCAAAAGGTTTAAGAAATAGAATTATAACTGTAAAGATGTTTATTTCAGGCATTGGAT 
4501  A~-I-~-~TI'ACTTTAGA~GCATAATGTTTCTGGATTTACATACTGTAACATT  CAGGAA~CTTGGAGAAC~TGGGTTTATTCACT  C~ACTCTAGTGCG 
4601  GTTTACTCACTGCTGCAAATACTGTATATTCAGGACTTC•AAAC•AAATGGTGAATGCCTATGGAACTAGTGGATCCAAACTGATCCAGTATAAGACTACT  G 
4701  AATCTGCTACCAAAACAGTTAATCAGTC~GTCGAGTGTTCTA~-~F~F~.G~G~CCT~CCCTATCTGTATTCCCAAAAA~f  ACT~GC~AATTT 
4801  AACA~AACTTTAAA~TGT~TFi~l~ATTGTAAAAATGGCAGGGGGTGGAATTATTACTCTATACATTCAACAGAGACTGAATAGATATGAAAGCT  GATTT 
4901  "ITX-I-X  /~ATTA(~CATGCTTCACAATGTTAAGTTATATGGGGAGCAACAGCAAACAGGTGCTAATTTt~-~.~fGGATATAGTATAAGCAGTGTCTGTGTTTTG 
5001  AAAGAATAGAACACAGTTTGTJ~'TGCCACTGTS~-I-F~-?  GGG~"FF~'I-I-*-I'CTTTTTCCGGAAAATCC~AAACCTTAAC~TACTAAGGACGTT  GTT 
5101  TTC~ACTTC~TTCTTAGTCACAAAATATATTTTGTTTACAAAAATTTCTGTAAAACAGGTTATAACAGT  GTTTAAAGTCTCAGTTTCTTGCTTG 
5201  GGGAACTTGTGTCCCTAATGTGTTAGA~GCTAGATTGCTAAC-C~GCTGATACTTGACAG~n-I'FI~GACCTGT  GTTACTAAAAAAAAGATGAATGTCGG 
5301  AAAAGGGTGTT~GGGTGGTCAACAAAGAAACAAAGATGTTATGGTG~AGACTTATGGTTGTTAAAAATGT  CATCTCAAGTCAAGTCACTGGTCT G 
5401  TTTC~TTTGATACA2~FFF~GTACTAACTAGCATTGTAAAATTATTTCATGATTAGAAATTACCTGTGGATATTTGTATAAAAGTGT~ 
5501  TATAAAAGTGTTCATTGTTTCGTAACACAGCATTGTATATGTGAAGCAAACTCTAAAATTATAAATGACAACCTGAATTATCTATTTCATCAAAAAAAAA 
5601  AA~CTTTAT  GGGCACAACT  GG 
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1987;  Kajiji et al.,  1989) similar to the integrin 0/subunits 
0/5, o/v, 0/,tB, and 0/Ps2. In the region of a6 corresponding to 
this  potential  cleavage site  (residues  899-923),  there  are 
three sets of dibasic residues. The use of two of these sites 
could account for the appearance of the smaller polypeptide 
as a doublet on SDS-polyacrylamide gels (Sonnenberg et al., 
1987).  This  doublet  may  also  arise  from  differences  in 
glycosylation at the two sites present in the light chain. The 
sequence RKKRE, which most closely resembles the cleav- 
age site of other integrin 0/chains,  is at position 899-903. 
Cleavage at this site would result in the formation of a heavy 
chain of 118,000 Mr and a light chain of 24,000 Mr,  which 
are  close to the  125,000 Mr and  30,000 Mr  estimated by 
SDS-PAGE. 
Comparison  of  or6 with the Other Integrin oe Subunits 
Alignment with the other integrin 0/subunits shows that 0/6 
shares  several structural features with these proteins (Fig. 
3).  Of the 20 cysteines in the mature or6 protein,  11  are in 
equivalent positions to those found in the other 10 t~ chains, 
5 are shared with 9 of the other 10 alphas, and 2 are shared 
with the other 5 0/chains which do not contain the I domain. 
One cysteine (residue 1039) is shared with the PS2 0/chain, 
and  another cysteine (residue 643)  is  unique to 0/6. Cys- 
teine 643 is in a region of the molecule (residues 641-689) 
in which two gaps of  about 15 and 9 amino acids were placed 
in the other 0/ chains  in order to optimize the alignment. 
Three of the four putative cation binding sites of 0/6 align 
with similar sites in the other 0/subunits.  A fourth weakly 
homologous  cation  binding  site  (residues  230-238)  pre- 
cedes, slightly, the cation binding sites present in the other 
c~ chains which lack the I domain. The cytoplasmic domain 
of 0/6 contains  the  sequence GFFKR  which  is  absolutely 
conserved in all but the Drosophila PS2 0/subunit, where the 
K  is replaced by an N. 
Some of the integrin 0/chains contain additional polypep- 
tide sequence. 0/2 and the 0/chains associated with 32 (O/L, 
O/M, 0/p,so) contain an insert domain (I domain) near the amino 
terminus of these molecules and the Drosophila PS2 0/sub- 
unit contains an insert just preceding the transmembrane por- 
tion of this molecule. 0/6 does not contain either of these in- 
serts. 
Based  on  the  alignment  shown  in  Fig.  3,  o/6  shares 
18-26% identity with the other integrin alpha subunits. The 
highest homology is with o/v, 0/5, and 0/Ps2 (25-26%  iden- 
tity) and the lowest homology is with those 0/chains which 
contain the I-domain (18%  identity). 
Further Evidence for the Identity of the so cDNA 
Clones and Association of  ~6 with Both/34 and/3i 
A  rabbit antiserum  (anti-o/6 cyto) was  prepared to a  syn- 
thetic peptide corresponding to the last 15 amino acids of the 
deduced a6 amino acid sequence.  This antiserum precipi- 
tated the 0/6/34 complex from a radiolabeled FG lysate (Fig. 
4 A), indicating that the cDNA clones isolated in this study 
encode the 0/6 protein. We then tested this antiserum with 
platelets that express 0/6~1 (Sonnenberg et al.,  1987) but not 
oe634. Fig.  4  B  shows  that this antiserum precipitated the 
0/6/3~ complex  from  a  radiolabeled  platelet  lysate.  These 
results provide further evidence that 0/6 forms stable hetero- 
dimers with both B~ and 34 (Hemler et al.,  1989). However, 
they do not exclude the possibility of slight structural varia- 
tions  in  0/6 which  may be responsible for preferential as- 
sociation with either of the 3  chains. 
Isolation  of  cDNA Clones Encoding ~4 
The cDNA for/34 was isolated by antibody screening of a 
phage expression library followed by colony hybridization of 
two plasmid libraries (see Materials and Methods) (Fig. 5 
A).  Overlapping clones covering •5.9  kb were sequenced 
(Fig.  1 B)  and  shown to encode /34 protein because:  (a) 
they contain an ORF of 1,822 amino acids starting with a 27- 
residue putative signal peptide followed by a  13 amino acid 
sequence identical to the B4 protein amino terminus we pre- 
viously determined (Kajiji et al.,  1989); (b) their nucleotide 
sequence is essentially identical to that of recently reported 
~4 cDNA clones from normal epithelial cells (Suzuki and 
Naitoh,  1990; Hogervorst et al.,  1990), with the exception 
of two locations described in detail below. To summarize the 
salient features, the mature ~4 protein contains a 710 amino 
acid  extracellular domain,  showing obvious sequence ho- 
mology to integrin/3 chains (including cysteine conservation 
at 47/56 positions),  followed by a predicted 23 amino acid 
transmembrane region, and finally  1,089 amino acids that 
presumably  represent an  unusually  large cytoplasmic do- 
main.  The total mass of the mature protein is 200,000 or 
212,500 if all five extracytoplasmic putative N-glycosylation 
sites are used. 
To test  whether or  not  the  large  carboxyl-terminal se- 
quence was part of the ~4 protein in complex with 0/6, a na- 
tive FG lysate was immunoprecipitated with the antibodies 
eluted from the cytoplasmic domain fusion protein (clone 
lam-I 8.2. I). These antibodies precipitated a complex of pro- 
teins with SDS-PAGE mobilities identical to those of authen- 
tic 0/d3, heterodimers (Fig.  5 B). 
Evidence  for Possible Multiple Forms of  3, mRNAs 
Some of the cDNA clones were found to contain insertions 
in two locations: one insertion was identified in the 5'-un- 
translated region, and the other in the coding region corre- 
sponding to the cytoplasmic tail. 
Thirteen independent clones, covering the 5' end of the/34 
cDNA, were sequenced. Six of them had an insertion of 49 
Figure 2. Nucleotide sequence and deduced amino acid sequence of the human c~6 subunit. The sequence corresponding with the amino- 
terminal sequence determined on a6 protein (Kajiji et al., 1989) is underlined. The putative transmembrane region is shown by a dashed 
underline. The arrowhead marks the position of cleavage between the signal sequence and the mature protein. Cysteines are circled. Poten- 
tial sites of N-linked glycosylation are shown in bold face. Closed boxes outline the putative cation binding domains. Dashed boxes outline 
dibasic residues that may represent sites of cleavage in the formation of a heavy and a light chain. The cytoplasmic sequence GFFKR, 
which is conserved in virtually all of the integrins o~ chains, is denoted by a stippled dashed box. A potential polyadenylation signal is 
boxed. These sequence data are available from EMBL/GenBank/DDBJ under accession number X53586, 
Tamura et al. Primary. Structure ofa6~4  1597 Figure 4.  Immunoprecipitation  of a~4  and 
ct6B~ with anti-o/6 cyto, an antibody raised to a 
synthetic peptide corresponding to the carboxy 
terminus  of u6.  (A)  Autoradiogram  of im- 
munoprecipitations  of a  detergent  lysate  of 
[~sS]methionine-labeled FG cells analyzed by 
SDS-PAGE under reducing (R) or nonreducing 
(N) conditions. Antibodies used were: anti-o/6 
cyto (lanes 1), antiserum 5710 (lanes 2), and 
the monoclonal antibody $3-41 (lanes 3), both 
to 0/6/~4. (B) Autoradiogram  of a SDS-PAGE 
analysis  of immunoprecipitations  of 1251 sur- 
face-labeled platelets with the monoclonal an- 
tibody to ~6, GoH3 (lanes 1), and the antise- 
rum anti-o/6 cyto (lanes 2). 
bp in the 5' untranslated  sequence after position  129,  9  bp 
upstream of the ATG initiation codon (Fig.  6). 
The second insertion sequence was found in the cytoplas- 
mic tail where, in one out of the five clones analyzed, there 
was an insertion of 70 amino acids precisely in frame be- 
tween threonine  1369 and glutamic acid 1440,  located after 
bp 4294  (Fig.  6). 
These extra sequences raised the possibility that multiple 
forms of ~4 cDNA exist in carcinoma cells.  In addition,  a 
f14  cDNA  from  normal  epithelial  cells  recently  reported 
(Hogervorst et al.,  1990) contains a  159-bp sequence in the 
cytoplasmic region not present in any of our clones and lo- 
cated after base pair 4,744  (Fig.  6, arrowhead). 
To determine whether these sequences were actually pres- 
ent in cellular mRNAs, we amplified mRNAs from various 
cells using PCR. Oligonucleotide primers flanking the sites 
of insertion were synthesized (in one case, see Fig. 7 A, an 
internal  primer  was  used)  as  described  in  Materials  and 
Methods.  PCRs using the primers flanking the 5' region in- 
sert  generated  products,  consistent  with  the  two  types  of 
cDNA we found, i.e., with or without the 49-bp insert (248 
and 200 bp,  respectively; Fig.  7 B,  lanes 1 and 2),  in two 
carcinoma cell lines tested (FG and LoVo). Of these, only the 
200-bp  band  (i.e.,  without  the  insert)  was  obtained  from 
placental mRNA (Fig. 7 B, lane 3). Unexpectedly, one band 
of 260 bp was seen in placental amplification products, sug- 
gesting the possibility of additional insertions in this region. 
The  low  intensity  of the  bands  obtained  from  placental 
cDNA for the amplification of this region may be explained 
by low representation of 5' mRNA sequences due to degrada- 
tion during mRNA extraction from tissues. 
To confirm their identity, these PCR bands were subcloned 
and  sequenced.  From  FG  and  LoVo  PCRs,  clones  corre- 
sponding  to  the  200-  and  248-bp  bands  were  found  and 
shown  to contain  the correct nucleotide  sequences.  How- 
ever,  clones  for the 260-bp band,  as  well as clones from 
placenta  PCRs  were  not  obtained.  The  identity  of these 
bands deserves further study. 
Using oligonucleotide primers specific to the region con- 
taining the insert at 4,294 bp (Fig. 7 B, lanes 4-6), a band 
of 255-bp was amplified from both LoVo and FG cDNAs but 
not from placenta cDNA, suggesting that mRNA containing 
this insert is expressed in carcinoma but not in normal ceils. 
PCR  amplifications  with  primers  flanking  the  insert  at 
base pair 4,744 (Fig. 7 B, lanes 7-9) suggested that mRNAs, 
both with and without this insert, are present in placental tis- 
sue and that the form containing the insert is prevalent. In- 
stead,  LoVo and FG  carcinoma cell  mRNA produce only 
PCR  bands  corresponding  to  the  insert-minus  form.  The 
identity of the 144-,  255-, and 354-bp bands was confirmed 
by the sequences of subclones from the respective PCRs. 
These results  suggest that  multiple  alternatively  spliced 
forms of f14 may exist in normal as well as transformed epi- 
thelial cells. 
Cellular Distribution of te~ 
The long cytoplasmic tail of ~/4 is suggestive of unique in- 
teractions with cytoskeletal components. To gain some infor- 
mation on this possibility, the cellular distribution  of c¢6~4 
with  respect  to  adhesion  plaques  was  examined  by  im- 
munofluorescence studies.  FG carcinoma cells were plated 
on Matrigel-coated glass, fixed, permeabilized, and stained 
by specific antibodies after 2 d of culture.  The majority of 
the cells in these cultures had a typical epithelial appearance, 
forming clusters of 3-20 cells with epithelioid geometry, as 
Figure 3. Alignment of 0/6 deduced amino acid sequence with the other integrin 0/subunits.  The other 0/chains  are from human sources 
except where noted: 5  =  fibronectin receptor (Argraves et al.,  1987; Fitzgerald et al.,  1987), V -- vitronectin receptor (Suzuki et al., 
1987), liB =  gplIB (Poncz et al.,  1987), 4  =  VLA-4 (Takada et al.,  1989), 2  =  VLA-2 (Takada and Hemler,  1987), P150 (Corbi et 
al.,  1987), M =  MacI (Arnaout et al.,  1988; Corbi et al.,  1988), L =  LFAI (Larson et al., 1989); M(M) =  murine MacI (Pytela,  1988), 
and the position specific (PS2) c~ chain from Drosophila (Bogaert et al.,  1987). Initial alignment was generously provided by Dr. Robert 
Pytela and modified to include the 0/6 sequence with the aid of sequence comparison programs (Devereux et al.,  1984). Closed circles 
and open circles represent positions were a residue is conserved among all 11 0/chains or in 10 of 11 chains, respectively. Inverted u'iangles 
denote residues found in all six (closed) or five or six (open) of the 0/subunits which do not contain the I-domain. Potential cation binding 
sites are boxed with a closed line and a highly conserved cytoplasmic  sequence (GFFKR)  is boxed with a dashed line. 
Tamura et al. Primary  Structure ofcr6~4  1599 Figure 5. Immunoprecipitation of/34 with anti- 
bodies selected with the lam 18.2.1 fusion pro- 
tein.  (A) Antibodies eluted from plaques lam 
23.1.1  (lanes  1),  lam 8B  (lanes 2),  and  lam 
18.2.1 (lanes 3) were used for immunoprecipi- 
tations  of a denatured  [35S]methionine FG ly- 
sate and analyzed by SDS-PAGE under reduc- 
ing (R) or nonreducing (N) conditions. (B) ~4 
specific monoclonal  antibody, AA3 (lanes 1) 
and antibodies eluted from plaque lain  18.2.1 
(lanes 2) were used for immunoprecipitations 
of a  nondenatured  [35S]methionine FG lysate 
and analyzed by SDS-PAGE. 
evidenced by phase-contrast microscopy (Fig. 8, 1 A, 2 A, and 
3 A). That these cells form adhesion plaques was shown by 
staining with antibodies to vinculin and talin, which can be 
visualized as spots on the external edges of spread cells in 
the periphery of the clusters (Fig.  8,  1 B and 3 B).  Actin, 
specifically stained by fluorescent phalloidin,  was also ob- 
served on  the  outer  edges  of spread  cells  in  a  pattern  of 
spikes, and on the inside of these cells in small patches (Fig. 
8, 2 B). However, no clearly recognizable actin stress fibers 
were seen. 
In cells stained simultaneously for both talin and/34,  the 
talin staining on the outer edges was often juxtaposed to that 
of/34 (Fig. 8, 3 B and 3 C, arrows) but was not overlapping. 
In parts of the basal surface interior to the edge of the cells, 
talin was not detectable, while/34 was visible and appeared 
to be arranged in small patches and streaks (Fig. 8, 3 C, ar- 
rows).  Cells double-stained with both anti-vinculin (mouse 
monoclonal)  and  anti-a6  cytoplasmic tail  (rabbit antibod- 
ies) gave very similar patterns to the cells double stained for 
talin and/34  (not shown). These results suggest that the cel- 
lular distribution  of a~4  is distinct  from that of adhesion 
plaques. 
Discussion 
We  have  isolated  cDNA  clones  encoding  both  a  and  /3 
subunits of the epithelial integrin,  ct6/34. The ct subunit was 
sequenced from two overlapping clones encoding a protein 
of  1,073 amino  acids.  Identification of these  clones  as  c~6 
came from two pieces of evidence. First, the ORF contained 
a sequence that matched exactly the sequence of the amino 
terminus of the mature ct6 protein (Kajiji et al.,  1989).  Sec- 
ond,  an antiserum to a  synthetic peptide corresponding to 
the putative ~6 carboxy terminus in the ORF recognized the 
O~6/34 complex in immunoprecipitations of radiolabeled car- 
cinoma cell lysates. 
Structurally,  a6  is  very  similar  to  the  other  integrin  ct 
subunits  that have been cloned to  date.  It shares 23-26% 
identity with those subunits which do not contain the I do- 
main insert (cts, av,  ~r~,  c~4, and Ctps2) and '~18%  identity 
with those c~ chains that do contain it (a~, C~L, aP150, and c~2) 
(see alignment shown in Fig.  3). 
All of the integrin a  proteins contain three potential cation 
binding sites.  A  fourth potential site exists in four of the c~ 
chains  which do not contain the I  domain.  In contrast,  (~6 
lacks this fourth cation binding site which makes it,  along 
with a4, an exception to the the classification of integrin tx 
subunits proposed by Takada and Hemler (1989).  There is 
a site (residues 230-238) with weak homology to the cation 
binding site consensus sequence. However, this site does not 
align with a potential site in any of the other tx chains. It starts 
with an asparagine instead of an aspartic acid residue,  and 
it  contains  a  phenylalanine  where  an  aspartic  acid  or 
asparagine residue is expected. These differences are, for the 
moment, of unclear significance, and await elucidation from 
x-ray crystallographic data. 
Similar or identical forms of c~6 have been reported to as- 
sociate  with  either  of two  integrin  /3  subunits,  /3,  or  /34 
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Gc'rGc-GGG~  .GCTCA  Ct~,CG~GC-COCCCACC~CCCCCCC~AC 
L  G  E  E  L  D  L  R  R  V  T  W  R  L  P  P  E  L  I  P  R  L  S  A  S  S  G  R  S  S  D  A  E  A  P  T  A  P  R  T 
GACGGCGGCGC~~~CGCAGTGCGACAC~CCGG~G~TGC42CGGATGGA  GCACCAACTCCCT 
T  A  A  R  A  G  R  A  A  A  V  P  R  S  A  T  P  G  P  P  G  ~  H  L  V  N  G  R  M  D  F  A  F  P  G  S  T  N  S  L 
GCACAC-GATGACCACF.4~CCA~CTATGGCACCCA~~  AAGCACA  CA~CTACAACTCACTGA~ 
H  R  M  T  T  T  S  A  A  A  Y  G  T  H  L  S  P  H  V  P  H  R  V  L  S  T  S  S  T  L  T  R  D  Y  N  S  L  T  R  S 
AGAACACTCACAC~2d%CCACA~cCCAGGGACTACTcCA~CTCCGTCTCCTCCCAC~C/t~x~C~Cc~T~ACT~cIv-.GT~GACA~~~ 
E  H  S  H  S  T  T  L  P  R  D  Y  S  T  L  T  S  V  S  S  H  D"  S  R  L  T  A  G  V  P  D  T  P  T  R  L  V  F  S  A 
CCTGGGGCCCACATCTCTCAGAGTGAGCTC~C-~~C~CC~GGGCTACAGTGTGGA~A~~~~~C  ..... 
L  G  P  T  S  L  R  V  S  W  Q  E  P  R  C  E  R  P  L  Q  G  Y  S  V  E  Y  Q  L  L  N  G  G  E  L  H  R  L  N  .....  1576 
1338 
1378 
1418 
1458 
1498 
1538 
5525  ....  ACCCTC~CAGCACCTCKI%Cd3CAC~CCTCACCCC~TGTGAOCCAC-C~GCOC~CACrGACCACCAC~A~~C~ 
•  .  T  L  G  A  Q  H  L  E  A  G  G  S  L  T  R  H  V  T  Q  E  F  V  S  R  T  L  T  T  S  G  T  L  S  T  H  M  D  Q  Q  1818 
5641  GTTCTTOCAAACTTGA~CCC~GCCCCACCCCCC~CATGTCCCACTAGGCGTCCTCC  GCCTCCTCAGCTACTCCATCCTTGCA  GOCC 
F  F  Q  T  *  1822 
5761  ACCCC-CATGCACAGAGC~AGGTGTCTCCT~GGCATGAAGGGGGCAAGGTCC  CCTATTTGTAACCAAAGA  CAAGGACCCAG 
5881  (DCTTr  GITCT  C41~CTTAATAAATGt  =~FFi"t  C-CTA~ 
Figure  6. Nucleotide sequence and deduced amino acid sequence of the human ~4 subunit, highlighting the regions where insertions oc- 
cur, presumably based on alternative mRNA splicing. The beginning and end of the sequence as well as the position of the predicted trans- 
membrane segment (dark bar underline) are shown for orientation.  The region containing the amino-terminal  sequence determined  on 
~4 protein  (Kajiji et al.,  1989) is underlined  with a lightly shaded bar. Alternate  splice regions are boxed. The arrowhead at base pair 
4,744 shows the site of insertion of 159-bp stretch reported by Hogervorst et al. (1990)• The complete sequence data (5, 918 bp) are available 
from EMBL/GenBank/DDBJ  under accession number X53587. 
(Hemler et al.,  1989).  We present further evidence of this 
alternative association. Antiserum raised to a synthetic pep- 
tide  corresponding  to  the  carboxy  terminus  of 0/6  reacts 
with  both  O/6~  4  from pancreatic  carcinoma cells and  0/6~1 
from human platelets.  This reinforces the evidence, which 
includes  identical amino-terminal sequences  (Kajiji et al., 
1989;  Hemler et al.,  1989) and the sharing of monoclonal 
antibody epitopes and peptide maps (Hemler et al.,  1989), 
for a  close structural  similarity between the 0/6 molecules 
associated with either ~4 or ~1,  However, these results do 
not exclude the possibility that small structural differences, 
perhaps due to alternative exon splicing or posttranslational 
modifications, may be responsible for the differential associ- 
ation with either ~4 or/3,.  Alternatively, if such differences 
do not exist,  the relative affinities of ~4 and/3,  for a6 may 
regulate their association. 
In cells that express both ~,  and/34,  OL6 appears to form 
heterodimers  preferentially  with  ~4  as  observed  by  our- 
selves (DeLuca et al., 1990) and others (Hemler et al., 1989; 
Kennel et al.,  1989).  Regions unique to 0/6 may be relevant 
for this  preferential  association.  In this  regard,  two  short 
regions of the 0/6 molecule (554-561  and 641-690) are not 
present in the other 0/subunits (Fig. 3). Further experiments 
are needed to examine the possibility that they may be in- 
volved in the formation of heterodimers with ~4,  possibly 
by creating a higher affinity for ~, than/3,. 
The primary structure of the integrin subunit/34 showed 
some unusual features. Homology to other integrin/3 chains 
ends at the border of the extracytoplasmic region and the 
predicted  transmembrane region.  After this  point,  the  /34 
sequence is completely divergent, with the exception of two 
conserved residues (WK) positioned at the end of the trans- 
membrane region,  which  may,  therefore,  be essential  for 
structure or function.  While ~1,  /32, and/33  have cytoplas- 
mic tails of the same length (47 amino acids),  with many 
identifies or conserved substitutions, these sequences are en- 
firely absent from/34.  Instead, B4 contains a surprisingly large 
cytoplasmic domain comprised of >1,000 residues. The pre- 
diction  of a  long  cytoplasmic tail  for ~4  confirms  recent 
reports from two other laboratories which isolated similar 
cDNAs  from normal  epithelial  cells  (Suzuki  and  Naitoh, 
1990;  Hogervorst et al.,  1990). 
In addition,  we provide direct evidence that the putative 
cytoplasmic domain deduced from these cDNA clones is, in 
fact, part of the f14 protein (Fig. 5). Antibodies eluted from 
a fusion protein containing the carboxy terminus of the ORF 
of  these  cDNAs  immunoprecipitated  the  0/6~4 complex 
from nondenatured  lysates, and a  ~4-1ike protein from cell 
lysates in which the interaction of 0/6 with/34 was disrupted 
by denaturation.  Since the 205,000-Mr  form of ~4 can be 
accounted for entirely by the size of the polypeptide back- 
bone and the addition of N-linked carbohydrates, our previ- 
Tamura et al. Primary Structure of oL6~4  1601 Figure  7. PCR products from carcinoma and 
placental  cDNA primed with oligonucleo- 
tides  for potential  alternative  splice  sites. 
(A) Diagrams  illustrating the location and 
expected size of PCR products.  Solid lines 
represent  the regions of the cDNAs being 
amplified. The boxes with vertical lines rep- 
resent the potential inserts observed in this 
study, and the box with diagonal lines repre- 
sents the potential insert in the/34 sequence 
reported by Hogervorst et al. (1990). Num- 
bers to the left of each line are the size of 
the expected PCR product. Numbers above 
each  line are the nucleotide positions just 
preceding the insert based on the number- 
ing scheme shown in Fig.  6.  Position and 
orientation of primers is indicated by the ar- 
rowheads.  Oligonucleotides  are described 
in Materials and Methods:  1 + 2 were used 
for insert  129, 3  +  4 were used for insert 
4,294, and 5 + 6 were used for insert 4,744. 
(B) PCR products from FG cDNA (lanes 1, 
4, and 7), LoVo  cDNA (lanes 2, 5, and 8), 
and placental cDNA (lanes 3, 6, and 9) were 
analyzed  on  a  polyacrylamide  gel  as  de- 
scribed  in Materials  and Methods. 
ous  suggestion  that  the  three different forms of/3,  (Mr  = 
205,000,  180,000,  and  150,000,  Kajiji et al.,  1989)  may be 
due to large amounts of sialic acid appears to be incorrect. 
Proteolytic cleavage may be a more accurate explanation for 
the heterogeneity in the molecular mass of/34 as suggested 
by others (Hemler et al.,  1989). 
The/34 sequences we obtained from carcinoma cells con- 
tain a  few differences compared to the/34 cDNAs isolated 
from normal epithelial cells (Hogervorst et al., 1990; Suzuki 
and Naitoh, 1990). A 49-bp insertion located 9-bp upstream 
of the  ATG  translational  start  site  was  found  in  6  of  13 
cDNAs we sequenced. It is possible that this region may be 
of regulatory  importance (e.g.,  for translation  efficiency). 
Furthermore, we found clones encoding two versions of the 
cytoplasmic  tail  of ~4.  One  of these  is  identical  to  that 
reported by Suzuki and Naitoh (1990).  The other contains 
an insertion of 70 amino acids after threonine  1,369.  Both 
of our sequences are different from that reported by Hoger- 
vorst et al. (1990),  which contains an insertion of 53 amino 
acids after histidine 1,519.  Thus, it appears that the/34 cyto- 
plasmic domain can exist in at least three versions. 
A likely explanation for some or all of these insertions is 
alternative exon splicing of primary mRNA transcripts. Such 
mechanisms  have been  described  in  many other  mRNAs 
(Smith et al.,  1989),  including the integrin subunits/33  (Van 
Kuppevelt et al., 1989) and PS2 c~ (Brown et al., 1989). Con- 
sistent  with  the  possibility  of alternative  splicing,  we de- 
tected PCR amplification products of the expected size using 
primers located either within or adjacent to the insertions. 
That mature cytoplasmic mRNA, rather than immature nu- 
clear transcripts, acted as templates in these PCR reactions 
is suggested by the fact that independent poly-(A)  +  RNA 
preparations yielded identical  results,  and that the relative 
ratio of the various forms remained constant within, and was 
characteristic of, a given cell type. For instance,  the 4,744 
insert was detectable in placenta but not in carcinoma cells, 
while the 4,294 insert had the opposite pattern (Fig.  7 B). 
Further experiments are, however, necessary to conclusively 
identify the  origin of the  multiple forms of the  /34  mRNA 
and to gain insight into their functional significance. In par- 
ticular, it is necessary to verify the existence of distinct pro- 
tein forms corresponding to the three versions of the/34  cy- 
toplasmic domain. 
The unique cytoplasmic domain of/34 suggests intracellu- 
lar interactions distinct from those of other integrins. When 
engaged with extracellular matrix ligands,  several types of 
integrins  participate  in  the  formation of structures  called 
adhesion plaques (or focal adhesions) characterized by the 
colocalization of integrin receptors with the adhesion plaque 
components vinculin and talin,  and with the ends of actin 
stress fibers (Buck and Horwitz, 1987). By immunostaining, 
we have shown here that the ~6/34 integrin is localized at the 
basal surface of adhering carcinoma cells (i.e.,  in areas of 
the plasma membrane contacting  substrate).  However, the 
distribution of c~6/34 is distinct from that of talin,  suggesting 
that c~d~4 may not participate in adhesion plaque formation 
The Journal  of Cell Biology, Volume 111, 1990  1602 Figure 8. Immunofluorescence staining of FG carcinoma cells. The cells were cultured  on Matrigel-coated glass coverslips for 2  d, and 
then fixed and detergent permeabilized. (1 A) Phase contrast;  (1 B) anti-vinculin antibodies. (2 A) Phase contrast;  (2 B) phalloidin (actin- 
binding).  (3 A) Phase contrast;  (3 B) anti-talin  antibodies;  (3 C) simultaneous staining with anti-/34 antibodies.  The plane of focus was 
kept at the basal surface of the cells. In 3 B and 3  C areas of interest are indicated as follows: (a) wavy arrows, areas internal  to the edges 
stained by anti-/34 antibodies but not anti-talin  antibodies;  (b) straight  arrows,  areas on the edges of peripheral,  spread  cells where talin 
and/34 staining are juxtaposed but not overlapping;  (c) arrowheads,  areas where talin and/34  staining were observed by careful focussing 
to be distinct.  See text for further  explanations.  Bar,  10 #m. 
in adhering carcinoma cells. It is possible that an inappropri- 
ate substrate was used in our experiments, as the ligand of 
0/6/$4  is  not  biochemically  identified.  However,  we  have 
made similar observations on cultured keratinocytes that can 
be  detached by anti-/$4 antiserum  (DeLuca et  al.,  1990). 
Together with  the unusual  /34 cytoplasmic tail,  these data 
suggest  that  the  biology  of 0/6/34 may  differ  substantially 
from other well-characterized integrins. 
In  conclusion,  while  the  role  of 0/6/$4 in  epithelial  cell 
adhesion  remains  to  be established,  the availability of 0/6 
and/$4 cDNAs should now facilitate this task. 
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Note Added in Proof The sequence of c¢3 from hamster was recently pub- 
lished (Tsuji, T., F. Yamamoto, Y. Miura, K. Takio, K. Tatani, S. Pawar, 
T.  Osawa,  and  S.  Hakomori.  1990.  J.  Biol.  Chem.  265:7016-7021). 
Alignment with  the  t~6  amino acid  sequence resulted  in  37%  identity, 
significantly higher than all other integrin ot chains. 
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